Meet the Expert: Amgen - Patient perspectives in moderate PsA: How tailored treatment can improve the patient experience


Industry room 3
English
Meet the Experts
04 June 2021 15:00 - 15:30

Learning Objectives:

  • Demonstrate the burden of disease in patients with early and moderate PsA
  • Acknowledge and demonstrate the burden of disease for early and moderate PsA through understanding how current and recently published literature can expand the knowledge base
  • Demonstrate the value of a tailored approach to the management of early and moderate PsA through review and discussion of the current treatment landscape and the benefit:risk profiles of different treatment options
  • Demonstrate the value of systemic PDE4 inhibitors as an effective treatment option that targets the complex clinical manifestations (both articular and extra-articular) of early and moderate PsA with a positive benefit:risk profile

Presentations

Title Time Calendar .ics
Introductions
04 June 2021 15:00 - 15:02 .ics
The dermatologist’s perspective
04 June 2021 15:02 - 15:07 .ics
The rheumatologist’s perspective
04 June 2021 15:07 - 15:12 .ics
Tailoring treatment
04 June 2021 15:12 - 15:17 .ics
Discussion and Q&A: Tailoring treatment
04 June 2021 15:17 - 15:29 .ics
Summary and close
04 June 2021 15:29 - 15:30 .ics